Operating Lease, Right-of-Use Asset of Corvus Pharmaceuticals, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Corvus Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Corvus Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $927,000, a 226% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Corvus Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $927,000 +$643,000 +226% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,012,000 +$434,000 +75% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,095,000 +$230,000 +27% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $1,177,000 +$28,000 +2.4% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $284,000 -$1,139,000 -80% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $578,000 -$1,113,000 -66% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $865,000 -$1,088,000 -56% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,149,000 -$1,068,000 -48% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 $1,423,000 -$1,044,000 -42% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $1,691,000 -$1,021,000 -38% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $1,953,000 -$999,000 -34% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $2,217,000 -$973,000 -31% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $2,467,000 -$953,000 -28% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $2,712,000 +$1,448,000 +115% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $2,952,000 +$1,497,000 +103% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $3,190,000 +$1,542,000 +94% 31 Dec 2021 10-K 28 Mar 2023 2021 FY
Q3 2021 $3,420,000 +$1,595,000 +87% 30 Sep 2021 10-Q 01 Nov 2021 2021 Q3
Q2 2021 $1,264,000 -$732,000 -37% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 $1,455,000 -$708,000 -33% 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q4 2020 $1,648,000 -$679,000 -29% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $1,825,000 -$658,000 -26% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $1,996,000 -$638,000 -24% 30 Jun 2020 10-Q 30 Jul 2020 2020 Q2
Q1 2020 $2,163,000 -$618,000 -22% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $2,327,000 +$2,327,000 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $2,483,000 30 Sep 2019 10-Q 29 Oct 2019 2019 Q3
Q2 2019 $2,634,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $2,781,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 09 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.